Rob Dillard

DocwireNews

A novel artificial intelligence-based tool demonstrated superior performance in the diagnosis of head and neck squamous cell carcinoma (HNSCC) compared with ChatGPT. The results were <a href="https://pubmed.ncbi.nlm.nih.gov/39112556/" target="_blank" rel="noopener">published</a> in European Archives of Oto-Rhino-Laryngology.
The study assessed the use of the newly published LLM Claude 3 Opus and compared it with the most advanced LLM ChatGPT 4.0 for the diagnosis and therapy planning of primary HNSCC. The analysis took place in March 2024 on 50 consecutive primary head and neck cancer cases. The diagnostic and recommendation parameters were compared with recommendations from Claude 3 and ChatGPT 4.0, including clinical recommendation, explanation, and summarization, in addition to the Artificial Intelligence Performance Instrument.
The findings showed that Claude 3 achieved superior success scores for the diagnostic workup compared with ChatGPT 4.0 and provided treatment recommendations involving surgery, chemotherapy, and radiation therapy. With respect to clinical recommendations, explanation, and summarization, Claude 3 scored similarly to ChatGPT 4.0.
&#8220;This study is the first analysis of Claude 3 for primary head and neck cancer cases and demonstrates a superior performance in the diagnosis of HNSCC than ChatGPT 4.0 and similar results for therapy recommendations,&#8221; the researchers concluded. &#8220;This marks the advent of a newly launched advanced AI model that may be superior to ChatGPT 4.0 for the assessment of primary head and neck cancer cases.&#8221;

Laura Litwin

Exercise Significantly Improves Cancer-Related Fatigue in Patients With Advanced Lung Cancer

Lung Cancer

The Importance of Maintaining Health Amid the Holidays

Sleep Disorders

Can Artificial Intelligence Detect Asymptomatic Lung Cancer?

Latest News

Novel AI Tool Is Better Than ChatGPT at Diagnosing Head and Neck Cancer

Head and Neck Cancer

An artificial intelligence-based tool demonstrated superior performance in the diagnosis of head and neck squamous cell carcinoma.

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe